MGMT promoter methylation in malignant gliomas: ready for personalized medicine?
Top Cited Papers
- 8 December 2009
- journal article
- review article
- Published by Springer Science and Business Media LLC in Nature Reviews Neurology
- Vol. 6 (1), 39-51
- https://doi.org/10.1038/nrneurol.2009.197
Abstract
No abstract availableKeywords
This publication has 92 references indexed in Scilit:
- Molecular Predictors of Progression-Free and Overall Survival in Patients With Newly Diagnosed Glioblastoma: A Prospective Translational Study of the German Glioma NetworkJournal of Clinical Oncology, 2009
- Induction of MGMT expression is associated with temozolomide resistance in glioblastoma xenograftsNeuro-Oncology, 2009
- Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trialThe Lancet Oncology, 2009
- Rechallenge with temozolomide in patients with recurrent gliomasZeitschrift für Neurologie, 2009
- Genomic profiling of CpG methylation and allelic specificity using quantitative high-throughput mass spectrometry: critical evaluation and improvementsNucleic Acids Research, 2007
- Long-term survival with glioblastoma multiformeBrain, 2007
- O6‐methylguanine DNA methyltransferase and p53 status predict temozolomide sensitivity in human malignant glioma cellsJournal of Neurochemistry, 2006
- Frequent promoter hypermethylation and low expression of the MGMT gene in oligodendroglial tumorsInternational Journal of Cancer, 2004
- O6-methyl-guanine-DNA methyltransferase methylation in serum and tumor DNA predicts response to 1,3-bis(2-chloroethyl)-1-nitrosourea but not to temozolamide plus cisplatin in glioblastoma multiforme.2003
- DNA mismatch repair and O6-alkylguanine-DNA alkyltransferase analysis and response to Temodal in newly diagnosed malignant glioma.Journal of Clinical Oncology, 1998